Resumen de acción EBO
EBOS Group Limited se dedica a la comercialización, venta al por mayor y distribución de productos sanitarios, médicos, farmacéuticos y para el cuidado de los animales en Australia, Nueva Zelanda y el Sudeste Asiático.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
Recompensas
Análisis de riesgos
Competidores de EBOS Group Limited
Historial de precios y rendimiento
Historical stock prices | |
---|---|
Current Share Price | NZ$36.00 |
52 Week High | NZ$45.29 |
52 Week Low | NZ$33.50 |
Beta | 0.26 |
1 Month Change | 3.90% |
3 Month Change | -1.61% |
1 Year Change | -18.53% |
3 Year Change | 17.61% |
5 Year Change | 63.27% |
Change since IPO | 1,486.36% |
Noticias y actualizaciones recientes
EBOS Group (NZSE:EBO) Seems To Use Debt Quite Sensibly
Apr 25Some Confidence Is Lacking In EBOS Group Limited's (NZSE:EBO) P/E
Mar 21EBOS Group (NZSE:EBO) Will Pay A Dividend Of A$0.5951
Feb 24Recent updates
EBOS Group (NZSE:EBO) Seems To Use Debt Quite Sensibly
Apr 25Some Confidence Is Lacking In EBOS Group Limited's (NZSE:EBO) P/E
Mar 21EBOS Group (NZSE:EBO) Will Pay A Dividend Of A$0.5951
Feb 24EBOS Group Limited (NZSE:EBO) Just Released Its Half-Year Earnings: Here's What Analysts Think
Feb 23Returns At EBOS Group (NZSE:EBO) Appear To Be Weighed Down
Jan 23EBOS Group Limited's (NZSE:EBO) Business Is Trailing The Market But Its Shares Aren't
Dec 18An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 20% Undervalued
Nov 02Here's What To Make Of EBOS Group's (NZSE:EBO) Decelerating Rates Of Return
Oct 17EBOS Group (NZSE:EBO) Has A Pretty Healthy Balance Sheet
Oct 02EBOS Group's (NZSE:EBO) Upcoming Dividend Will Be Larger Than Last Year's
Aug 28Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)
Aug 02EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return
Jun 26Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)
May 02Is EBOS Group (NZSE:EBO) Using Too Much Debt?
Apr 14EBOS Group (NZSE:EBO) Could Be Struggling To Allocate Capital
Mar 14EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year
Feb 26A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)
Jan 06EBOS Group (NZSE:EBO) Might Be Having Difficulty Using Its Capital Effectively
Nov 28Here's Why EBOS Group Limited's (NZSE:EBO) CEO Compensation Is The Least Of Shareholders' Concerns
Oct 21EBOS Group Limited (NZSE:EBO) Shares Could Be 37% Below Their Intrinsic Value Estimate
Oct 05Does EBOS Group (NZSE:EBO) Have A Healthy Balance Sheet?
Sep 13EBOS Group (NZSE:EBO) Will Pay A Larger Dividend Than Last Year At A$0.5116
Aug 26Slowing Rates Of Return At EBOS Group (NZSE:EBO) Leave Little Room For Excitement
Jun 24An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 30% Undervalued
May 10Return Trends At EBOS Group (NZSE:EBO) Aren't Appealing
Mar 17We Think That There Are Issues Underlying EBOS Group's (NZSE:EBO) Earnings
Feb 26EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year
Feb 18EBOS Group Limited's (NZSE:EBO) Intrinsic Value Is Potentially 41% Above Its Share Price
Jan 22Is EBOS Group (NZSE:EBO) Using Too Much Debt?
Dec 26EBOS Group (NZSE:EBO) Has Some Way To Go To Become A Multi-Bagger
Oct 31An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 23% Undervalued
Oct 18Is EBOS Group (NZSE:EBO) A Risky Investment?
Sep 19Here's Why I Think EBOS Group (NZSE:EBO) Might Deserve Your Attention Today
Aug 05A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)
Jul 13EBOS Group's (NZSE:EBO) Returns Have Hit A Wall
Jun 09Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?
May 01Here's Why EBOS Group (NZSE:EBO) Can Manage Its Debt Responsibly
Apr 08A Look At The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)
Mar 27Is EBOS Group Limited's (NZSE:EBO) Recent Performance Tethered To Its Attractive Financial Prospects?
Mar 15Is EBOS Group Limited (NZSE:EBO) A Smart Pick For Income Investors?
Mar 03Analysts Are Updating Their EBOS Group Limited (NZSE:EBO) Estimates After Its Half-Year Results
Feb 19Has EBOS Group (NZSE:EBO) Got What It Takes To Become A Multi-Bagger?
Feb 09With EPS Growth And More, EBOS Group (NZSE:EBO) Is Interesting
Jan 27EBOS Group (NZSE:EBO) Has Gifted Shareholders With A Fantastic 147% Total Return On Their Investment
Jan 14Estimating The Fair Value Of EBOS Group Limited (NZSE:EBO)
Dec 26EBOS Group Limited's (NZSE:EBO) Stock Has Fared Decently: Is the Market Following Strong Financials?
Dec 14Rentabilidad de los accionistas
EBO | NZ Healthcare | Mercado NZ | |
---|---|---|---|
7D | 5.0% | 0.6% | 0.9% |
1Y | -18.5% | -13.1% | -4.3% |
Rentabilidad vs. Industria: EBO obtuvo unos resultados inferiores a los del sector NZ Healthcare , que el año pasado arrojó un rendimiento del -13.8%.
Rentabilidad vs. Mercado: EBO obtuvo unos resultados inferiores a los del mercado NZ, que fue del -5.1% el año pasado.
Volatilidad de los precios
EBO volatility | |
---|---|
EBO Average Weekly Movement | 3.0% |
Healthcare Industry Average Movement | 4.5% |
Market Average Movement | 4.1% |
10% most volatile stocks in NZ Market | 7.6% |
10% least volatile stocks in NZ Market | 2.5% |
Precio estable de las acciones: EBO no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de EBO (3%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
Fundada | Empleados | CEO | Página web |
---|---|---|---|
1922 | 5,000 | John Cullity | www.ebosgroup.com |
EBOS Group Limited se dedica a la comercialización, venta al por mayor y distribución de productos sanitarios, médicos, farmacéuticos y para el cuidado de animales en Australia, Nueva Zelanda y el Sudeste Asiático. Opera a través de los segmentos Healthcare y Animal Care. La empresa ofrece servicios de logística sanitaria; soluciones de gestión de medicamentos; software de gestión de farmacias; servicios de fidelización, genéricos, cumplimiento, inteligencia empresarial y software para tiendas; y servicios de comunicación, programas y consultoría en materia de salud.
Resumen de fundamentos de EBOS Group Limited
Estadísticas fundamentales de EBO | |
---|---|
Capitalización bursátil | NZ$6.96b |
Beneficios(TTM) | NZ$282.93m |
Ingresos (TTM) | NZ$13.93b |
24.6x
Ratio precio-beneficio (PE)0.5x
Ratio precio-ventas (PS)¿Está EBO sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
Cuenta de resultados (TTM) de EBO | |
---|---|
Ingresos | AU$12.67b |
Coste de los ingresos | AU$11.09b |
Beneficio bruto | AU$1.58b |
Otros gastos | AU$1.33b |
Beneficios | AU$257.35m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
Aug 21, 2024
Beneficios por acción (BPA) | 1.33 |
Margen bruto | 12.49% |
Margen de beneficio neto | 2.03% |
Ratio deuda/patrimonio | 62.3% |
¿Cómo se ha desempeñado EBO a largo plazo?
Ver rendimiento histórico y comparativa